Comparing the Safety and Efficacy of Myasthenia Gravis Treatments: A Bayesian Network Metaanalysis Accounting for Inconsistencies in Trial Designs and Populations (P11-9.019)

Bhaskar Roy; Nilay McLaren; Wayne Zhong; Sheena Hussain; Richard Nowak

doi:10.1212/wnl.0000000000217618

June 9, 2026Neurology

Comparing the Safety and Efficacy of Myasthenia Gravis Treatments: A Bayesian Network Metaanalysis Accounting for Inconsistencies in Trial Designs and Populations (P11-9.019)

View Full Paper

Ask AI

Bookmark

Share

Key Points

The aim is to compare the safety and efficacy of different myasthenia gravis treatments while addressing inconsistencies in trial data.
Utilized a Bayesian hierarchical model to analyze treatment outcomes.
Accounted for variations in trial designs and patient populations.
Conducted a meta-analysis to summarize findings across multiple studies.
Identified significant variations in efficacy rates across treatments.
Demonstrated varying safety profiles associated with different myasthenia gravis therapies.
Highlighted the importance of trial design consistency to improve treatment comparisons.

Implication

Bayesian analysis compares the efficacy and safety of myasthenia gravis treatments, suggesting better treatment strategies.

Abstract

We compared the efficacy and safety of myasthenia gravis (MG) treatments leveraging a Bayesian hierarchical model accounting for the inconsistencies in trial designs and populations.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Roy et al. (2026) studied this question.

synapsesocial.com/papers/6a2cf36efaef96ed7f055e96 https://doi.org/10.1212/wnl.0000000000217618

View Full Paper

Ask AI

Bookmark

Share

Comparing the Safety and Efficacy of Myasthenia Gravis Treatments: A Bayesian Network Metaanalysis Accounting for Inconsistencies in Trial Designs and Populations (P11-9.019)

Key Points

Implication

Abstract

Discussion

Cite This Study

Comparing the Safety and Efficacy of Myasthenia Gravis Treatments: A Bayesian Network Metaanalysis Accounting for Inconsistencies in Trial Designs and Populations (P11-9.019)

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading